Halder Venture Limited Receives Credit Rating Migration to 'Crisil BBB-/Stable' from Crisil Ratings

3 min read     Updated on 31 Mar 2026, 08:38 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Halder Venture Limited received a credit rating migration from Crisil Ratings, with long-term rating upgraded to 'Crisil BBB-/Stable' from 'Crisil BB+/Stable Issuer Not Cooperating' and short-term rating reassigned to 'Crisil A3' for total facilities worth Rs 387.27 crore. The company showed strong financial performance with operating income of Rs 870.88 crore in FY2025, up from Rs 646.19 crore in FY2024, and reported PAT growth of 80.9% to Rs 21.11 crore. The rating reflects the company's established market position in rice milling and edible oil processing over six decades, though it faces challenges from capital expenditure risks and working capital intensive operations.

powered bylight_fuzz_icon
36515339

*this image is generated using AI for illustrative purposes only.

Halder Venture Limited has received a significant credit rating update from Crisil Ratings Limited, with the rating agency migrating the company's long-term rating and reassigning its short-term facilities rating. The company formally intimated the stock exchanges about this development on March 31, 2026.

Rating Migration Details

Crisil Ratings has migrated the company's long-term rating to 'Crisil BBB-/Stable' from the previous 'Crisil BB+/Stable Issuer Not Cooperating' status. The rating agency has also reassigned 'Crisil A3' rating to the short-term bank debt facilities.

Rating Category Current Rating Previous Status
Long-term Rating Crisil BBB-/Stable Crisil BB+/Stable Issuer Not Cooperating
Short-term Rating Crisil A3 (Reassigned) -
Total Bank Loan Facilities Rs 387.27 crore -

The migration occurred after the company management started sharing requisite information necessary for carrying out a comprehensive review of the ratings, following a period where inadequate information had led to the 'Issuer Not Cooperating' status.

Financial Performance and Business Position

The Halder group, which includes multiple entities operating in rice milling and edible oil processing, demonstrated strong revenue growth with operating income reaching Rs 870.88 crore in fiscal 2025, compared to Rs 646.19 crore in fiscal 2024.

Financial Metric FY 2025 FY 2024 Change
Operating Income Rs 870.88 crore Rs 646.19 crore +34.7%
Reported PAT Rs 21.11 crore Rs 11.67 crore +80.9%
PAT Margin 2.42% 1.81% +0.61%
Adjusted Debt/Networth 1.94 times 1.76 times -
Interest Coverage 2.55 times 2.11 times -

The company's networth stood at Rs 153.33 crore with a gearing ratio of 1.94 times as of March 31, 2025. The debt protection metrics showed improvement with interest coverage and net cash accrual to total debt ratios of more than 2.55 times and 9% respectively in fiscal 2025.

Business Strengths and Market Position

Crisil Ratings highlighted the company's established market position built over six decades of promoter experience in the rice milling business since 1924. The company deals with over 1,000 wholesalers and retailers across East India and has prominent brand presence in the parboiled rice segment in overseas markets through its Bhojmoti, Moti, and Odaana brands.

The rating agency noted the company's moderate financial risk profile, supported by robust debt protection metrics and a moderate capital structure that cushions credit risk from sudden business condition changes.

Key Challenges and Risk Factors

The rating reflects several challenges facing the company:

  • Capital Expenditure Risks: The company has invested in a new unit in Haldia purchased from KS Oils, including storage tanks, packaging unit, and refinery, with total acquisition and renovation costs estimated at Rs 155 crore
  • Market Competition: Exposure to intense competition in edible oils industry and volatility in raw material prices
  • Working Capital Requirements: Operations remain working capital intensive with gross current assets at 190 days as of March 31, 2025

Facility-wise Rating Breakdown

The rated facilities include various banking arrangements across multiple lenders:

Facility Type Amount (Rs crore) Rating
Cash Credit Rs 306.00 crore Crisil BBB-/Stable
Term Loans Rs 78.17 crore Crisil BBB-/Stable
Non-Fund Based Limit Rs 3.10 crore Crisil A3

The company maintains banking relationships with major institutions including ICICI Bank, Bank of India, Axis Bank, Union Bank of India, and State Bank of India among others.

Outlook and Rating Sensitivity

Crisil Ratings maintains a stable outlook, believing the group will continue to benefit from its established brand presence and extensive promoter experience. The rating could see upward movement with swift ramp-up of new capex resulting in significant revenue growth and improved operating margins, while substantial decline in revenue and profitability could lead to downward pressure.

Historical Stock Returns for Halder Venture

1 Day5 Days1 Month6 Months1 Year5 Years
+4.18%+0.40%+1.10%-7.11%-7.11%-7.11%

How will the Rs 155 crore investment in the new Haldia unit impact Halder Venture's debt-to-equity ratio and overall financial leverage in the coming quarters?

What specific strategies is Halder Venture implementing to reduce its working capital cycle from the current 190 days and improve cash flow efficiency?

Given the intense competition in edible oils and volatile raw material prices, how might Halder Venture's profit margins evolve as the new capacity comes online?

Halder Venture Limited Announces Postal Ballot for Capital Increase and Convertible Warrants Issue

3 min read     Updated on 30 Mar 2026, 10:18 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Halder Venture Limited has issued a postal ballot notice for two key corporate actions. The company seeks to increase authorized share capital from Rs. 13.42 crore to Rs. 18.42 crore and issue 7,93,650 convertible warrants at Rs. 315 per warrant to raise Rs. 25 crore from P.K. Bio Link Pvt. Ltd. E-voting runs from March 31 to April 29, 2026, with results by May 1, 2026.

powered bylight_fuzz_icon
36434914

*this image is generated using AI for illustrative purposes only.

Halder Venture Limited has announced a postal ballot notice seeking shareholder approval for significant corporate restructuring initiatives. The company has proposed two key resolutions that will enhance its capital structure and funding capabilities.

Authorized Share Capital Enhancement

The company seeks approval to increase its authorized share capital substantially. The proposed enhancement involves expanding the capital base to accommodate future growth and conversion requirements.

Parameter: Current Structure Proposed Structure
Authorized Capital: Rs. 13,42,50,000 Rs. 18,42,50,000
Number of Shares: 1,34,25,000 1,84,25,000
Additional Shares: - 50,00,000
Face Value: Rs. 10 per share Rs. 10 per share

The increase in authorized share capital requires alteration to Clause V of the company's Memorandum of Association. This expansion will provide adequate headroom for the proposed convertible warrants and future capital requirements.

Convertible Warrants Issuance

The company proposes to issue convertible warrants on a preferential basis to non-promoter entities. The warrants will provide holders the right to convert into equity shares within a specified timeframe.

Details: Specifications
Number of Warrants: 7,93,650
Issue Price: Rs. 315 per warrant
Premium: Rs. 305 per warrant
Total Amount: Rs. 24,99,99,750
Allottee: P.K. Bio Link Pvt. Ltd.
Conversion Period: 18 months from allotment

Pricing and Valuation Framework

Since the company's equity shares are infrequently traded, the pricing follows SEBI ICDR Regulation 165 requirements. An independent registered valuer, CA Sanjay Jhajharia, conducted the valuation assessment.

Valuation Parameter: Amount
Minimum Price (Valuation Report): Rs. 314.79 per share
Approved Issue Price: Rs. 315 per share
Payment at Allotment: 25% of issue price
Balance Payment: 75% at conversion

Fund Utilization Strategy

The company plans to deploy the raised funds across two primary objectives, with equal allocation for each purpose.

Purpose: Allocation Timeline
Capital Expansion: Rs. 12,49,99,875 Within 6 months
Working Capital: Rs. 12,49,99,875 Within 6 months
Total: Rs. 24,99,99,750 -

The capital expansion funds will support business operations expansion, network strengthening, and strategic investments. Working capital augmentation will improve the company's overall financial health and support general corporate purposes.

Shareholding Impact Analysis

The preferential issue will result in shareholding pattern changes, with P.K. Bio Link Pvt. Ltd. acquiring a significant stake upon full conversion.

Shareholding Category: Pre-Issue (%) Post-Issue (%)
Promoter & Promoter Group: 73.70% 69.28%
Public Shareholding: 26.30% 30.72%
P.K. Bio Link Pvt. Ltd.: 0% 5.99%

The ultimate beneficial owners of P.K. Bio Link Pvt. Ltd. are Pronoy Bhattacharyya and Pritikona Bhattacharya. The transaction will not result in any change of control or management.

Voting and Timeline Details

The postal ballot process follows electronic voting procedures, with specific timelines established for shareholder participation.

Timeline Parameter: Date/Period
Record Date: March 27, 2026
E-voting Commencement: March 31, 2026 (10:00 AM)
E-voting Conclusion: April 29, 2026 (5:00 PM)
Results Declaration: By May 1, 2026
Warrant Allotment: Within 15 days of approval

Mr. Manoj Prasad Shaw, Practicing Company Secretary, has been appointed as the scrutinizer for the e-voting process. The company will conduct the entire voting process electronically, with notices sent only to shareholders with registered email addresses.

The resolutions require different approval thresholds - the capital increase needs ordinary resolution approval, while the convertible warrants issuance requires special resolution approval from shareholders.

Historical Stock Returns for Halder Venture

1 Day5 Days1 Month6 Months1 Year5 Years
+4.18%+0.40%+1.10%-7.11%-7.11%-7.11%

How will the significant capital infusion of Rs. 25 crores impact Halder Venture's competitive position and market expansion plans in their industry sector?

What strategic synergies might emerge from P.K. Bio Link's 5.99% stake acquisition, given the biotech connection suggested by their company name?

Will the improved public shareholding ratio of 30.72% make Halder Venture more attractive to institutional investors and improve stock liquidity?

More News on Halder Venture

1 Year Returns:-7.11%